Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Aclarion, Inc.ACON · Entity 8157 | Director | August 13, 2026 | August 17, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Aclarion, Inc.
Report date August 13, 2026 · Filed August 17, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 76,122 |
Reported balance
After 2026-08-13 transaction · row 1
1 source rowRow 1 · 2026-08-13 · Purchase · Acquired 21,122 · Balance 76,122 F1: The Reporting Person purchased common stock on the public market on 08/13/2026. |
Filing footnotes · ownership attribution and instrument terms
F1: The Reporting Person purchased common stock on the public market on 08/13/2026.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 13, 2026 Filed Aug 17, 2026 12:30 UTC | Aclarion, Inc. ACON · Entity 8157 | PurchaseCommon Stock | 21,122 | $2.37 | $50,059.14 |
DisclosureSEC source: 0001683168-26-006516 · ownership.xml · nonDerivative · entry 1 Bond Ryan · CIK 0001903191 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 76,122 F1 · shares: The Reporting Person purchased common stock on the public market on 08/13/2026. Read SEC document |
| June 11, 2026 Filed Jun 12, 2026 20:30 UTC | Aclarion, Inc. ACON · Entity 8157 | GrantCommon Stock | 55,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001683168-26-004815 · ownership.xml · nonDerivative · entry 1 Bond Ryan · CIK 0001903191 · Chief Strategy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,000 F1 · shares: The shares reported are restricted stock units ("RSUs") granted 6/11/2026 under the Company's equity incentive plan. Each RSU represents a contingent right to receive one share of ACON common stock. F2 · shares: 100% of the RSUs shall vest on 6/1/2027. Any outstanding and unvested RSUs will also accelerate and fully vest upon a change of control (as defined in the Company's equity incentive plan). Read SEC document |
| April 22, 2022 Filed Apr 25, 2022 21:28 UTC | Aclarion, Inc. ACON · Entity 8157 | PurchaseWarrants for Common Stock (right to buy) · Derivative | 21,000 | $0.73 Strike: $4.35 | $15,330.00 |
DisclosureSEC source: 0001683168-22-002905 · ownership.xml · derivative · entry 2 Bond Ryan · CIK 0001903191 · Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,527 Underlying: Common Stock · 21,000 shares Expires 2027-04-21 F1 · shares: The Reporting Person purchased common stock and warrants for common stock on the public market on 4/22/2022, which was the first day of trading after the Company's initial public offering ("IPO"). Each common stock warrant has an exercise price of $4.35 per common share, and may be exercised at any time up to five years from the date of issue. F1 · price: The Reporting Person purchased common stock and warrants for common stock on the public market on 4/22/2022, which was the first day of trading after the Company's initial public offering ("IPO"). Each common stock warrant has an exercise price of $4.35 per common share, and may be exercised at any time up to five years from the date of issue. F1 · derivative.underlying_shares: The Reporting Person purchased common stock and warrants for common stock on the public market on 4/22/2022, which was the first day of trading after the Company's initial public offering ("IPO"). Each common stock warrant has an exercise price of $4.35 per common share, and may be exercised at any time up to five years from the date of issue. Read SEC document |
| April 22, 2022 Filed Apr 25, 2022 21:28 UTC | Aclarion, Inc. ACON · Entity 8157 | PurchaseCommon Stock | 20,000 | $2.80 | $56,000.00 |
DisclosureSEC source: 0001683168-22-002905 · ownership.xml · nonDerivative · entry 1 Bond Ryan · CIK 0001903191 · Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 F1 · shares: The Reporting Person purchased common stock and warrants for common stock on the public market on 4/22/2022, which was the first day of trading after the Company's initial public offering ("IPO"). Each common stock warrant has an exercise price of $4.35 per common share, and may be exercised at any time up to five years from the date of issue. F1 · price: The Reporting Person purchased common stock and warrants for common stock on the public market on 4/22/2022, which was the first day of trading after the Company's initial public offering ("IPO"). Each common stock warrant has an exercise price of $4.35 per common share, and may be exercised at any time up to five years from the date of issue. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.